A P-32-Postlabeling assay for the oxidative DNA lesion 8,5 '-cyclo-2 '-deoxyadenosine in mammalian tissues - Evidence that four type II I-compounds are dinucleotides containing the lesion in the 3 ' nucleotide
K. Randerath et al., A P-32-Postlabeling assay for the oxidative DNA lesion 8,5 '-cyclo-2 '-deoxyadenosine in mammalian tissues - Evidence that four type II I-compounds are dinucleotides containing the lesion in the 3 ' nucleotide, J BIOL CHEM, 276(38), 2001, pp. 36051-36057
8,5 ' -Cyclopurine-2 ' -deoxynuelcotides, which are strong blocks to mammal
ian DNA and RNA polymerases, represent a novel class of oxidative DNA lesio
n in that they are specifically repaired by nucleotide excision repair but
not by base excision repair or direct enzymatic reversion. Previous studies
using thin layer chromatography of P-32-postlabeled DNA digests have detec
ted several bulky oxidative lesions of unknown structure, called I-compound
s, in DNA from normal mammalian organs. We investigated whether any of thes
e type II I-compounds contained 8,5 ' -cyclo-2 ' -deoxyadenosine (cA). Two
previously detected type II I-compounds were found to be dinucleotides of t
he sequence pAp-cAp and pCp-cAp. Furthermore, a modification of the techniq
ue resulted in detection of two additional I-compounds, pTp-cAp and pGp-eAp
. Each I-compound isolated from neonatal rat liver DNA matched authentic P-
32-labeled cA-containing chromatographic standards under nine different chr
omatographic conditions. Their levels increased significantly after normal
birth. The P-32-postlabeling technique used here is capable of detecting 1-
5 lesions/diploid mammalian cell. Thus, it should now be possible to detect
changes of cA levels resulting from low level ionizing radiation and other
conditions associated with oxidative stress, and to assess cA levels in ti
ssues from patients with the genetic disease xeroderma pigmentosum who are
unable to carry out nucleotide excision repair.